Clinical Trials on PCSK9
Total 13 results
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
Shanghai Tong Ren HospitalRecruitingEarly PCSK9 Inhibitor on Ventricular RemodlingChina
-
Charite University, Berlin, GermanyUnknownHomozygous or Compound Heterozygous POMC, LEPR or PCSK1 Gene MutationGermany
-
First Affiliated Hospital of Harbin Medical UniversityRecruiting
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal
-
Soleno Therapeutics, Inc.Not yet recruitingSH2B1 Deficiency Obesity | Obesity Associated With PCSK1 Mutation (rs6232 Variant) | SIM1 Deficiency Obesity
-
Sun U. KwonNot yet recruitingStroke, Acute Ischemic | PCSK9 InhibitorKorea, Republic of
-
Shenzhen People's HospitalInnovent Biopharmaceutical Co., Ltd.Active, not recruitingEfficacy and Safety | Heterozygous Familial Hypercholesterolemia | PCSK9China
-
Rhythm Pharmaceuticals, Inc.CompletedPOMC Deficiency Obesity | PCSK1 Deficiency Obesity | LEPR Deficiency ObesityTurkey
-
LG ChemNot yet recruitingPOMC Deficiency Obesity | PCSK1 Deficiency Obesity | LEPR Deficiency ObesityFrance, United Kingdom
-
Franck BoccaraInstitut National de la Santé Et de la Recherche Médicale, France; Amgen; National...CompletedDyslipidemias | HIV Seropositivity | PCSK9France
-
Rhythm Pharmaceuticals, Inc.CompletedBardet-Biedl Syndrome | POMC Deficiency Obesity | PCSK1 Deficiency Obesity | LEPR Deficiency ObesityUnited States, Australia, Spain, United Kingdom